Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02112149 · ClinicalTrials.gov registry record · Phase 3

Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors

A Phase 3 study, sponsored by Yale University.

Completed
Registry status
Phase 3
Development phase
200
Enrollment target

NCT02112149: Completed Phase 3 study, sponsored by Yale University.

NCT02112149 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 200 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02112149, a Phase 3 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 3
Development phase
200 participants
Enrollment target

Study Summary

The proposed study is a randomized trial evaluating the impact of the 12-week LIVESTRONG exercise program vs. waitlist control on cancer-related outcomes in 200 cancer survivors.

Primary Outcome

Modifiable Physical Activity Questionnaire will be used to assess physical activity levels at baseline and 3-months to examine whether the LIVESTRONG program led to maintenance or further increases in physical activity levels compared with participants randomized to control.

Interventions

  • BEHAVIORAL LIVESTRONG

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2013-02
Est. Completion 2015-12
Phase Phase 3
Yale University

1,492 total trials

What the finished NCT02112149 record still lists

NCT02112149 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).

The record links to 0 conditions, and to 1 intervention - of which LIVESTRONG is the first listed.

NCT02112149 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02112149 about?

NCT02112149 is a clinical study titled "Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors". The proposed study is a randomized trial evaluating the impact of the 12-week LIVESTRONG exercise program vs. waitlist control on cancer-related outcomes in 200 cancer survivors.

What is the current status of trial NCT02112149?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2013-02. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02112149?

The interventions under investigation include: LIVESTRONG (BEHAVIORAL).

Who is sponsoring clinical trial NCT02112149?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02112149's enrollment target sits among peer trials

200 1353rd of 2000 higher than 613 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02112149, the US trial registry maintained by the National Library of Medicine. NCT02112149 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.